Dr. Komrokji Discusses Myelodysplastic Syndromes

Video

Rami S. Komrokji, MD, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses the risk factors for developing myelodysplastic syndromes(MDS).

Rami S. Komrokji, MD, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses the risk factors for developing myelodysplastic syndromes(MDS).

Komrokji says the majority of the time, physicians don’t know why patients develop MDS. Researchers think that it is due to the process of aging and different environmental factors. There are also certain genetic components linked to MDS, but these are very rare. Smoking can also lead to the development of MDS, Komrokji says.

Patients can also develop MDS from being treated for chemotherapy for other diseases. Although researchers originally thought MDS from chemotherapy had to do with the damage of stem cells, Komrokji says new evidence suggests that these patients might have genetic alterations that make them predisposed.

Komrokji says there are no preventive measures set up for MDS, but perhaps in the future, researchers can better understand the disease and better identify patients who might be predisposed to developing this disease.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
Related Content